This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Evidence-Based Medicine  • Dermatologic Disorders, Other  • Alert me on articles by topic

Hywel C. Williams, MSc, PhD, FRCP

Arch Dermatol. 2004;140:1151-1152.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Commentary on: Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study
Berth-Jones J, Damstra RJ, Golsch S, Livden JK, Van Hooteghem O, Allegra F, Parker CA
BMJ. 2003;326:1367-1370

Question: How effective and safe is the addition of twice-weekly fluticasone propionate cream or ointment to regular emollient therapy for reducing relapses in people with chronic relapsing atopic dermatitis (AD)?
Design: Randomized, double-blind, parallel-group study.
Setting: Thirty-nine dermatology outpatient clinics in 6 European countries.
Participants: People with AD, as defined by the UK Working Party's refinement of Hanifin and Rajka's diagnostic criteria,¹ aged 12 to 65 years with moderate to severe disease who were experiencing a flare at study recruitment.
Interventions: For the first 4-week phase of the study, all participants were given 0.05% fluticasone propionate cream or 0.005% fluticasone propionate . . . [Full Text of this Article]

Comment

Queen's Medical Center, Nottingham, England